tamoxifen and glp-1 Agonists Poised to Impact Breast Cancer Care | Targeted Oncology 2 Years of Endocrine Therapy,

In order to fuel global expansion, companies are investing in developing new drugs in sustained release and oral modality, add capacity for production, enhance patient support programs, and write applications for regulatory approval of additional indications

Why Its a Milestone: "Discover in India": The 2026 theme focuses on "Leapfrogging Life-Sciences Innovation." Instead of just manufacturing existing drugs, India is now prioritizing the development of New Biological Entities (NBEs) and Biosimilars

Studies in humans should be done (42, 43) ( Table 1 )

10.1210/en.2013-2106 31 KimH.WrannC

A.BezverbnayaK.WangD.et al (2022)

While CPG new product launches have been in a lull recently, the emerging market demands visionary innovation. Addressing the ripple effects Food retailers, suppliers and manufacturers and restaurant/foodservice operators can mitigate the ripple effects of weight-loss drugs via a number of strategies, according to PwC